Asian Penny is seeing in July 2025

Simply Wall ST Financial Health Rating: ★★★★earch

Overview: Brii Biosciences Limited is involved with therapies for infection and central nervous system diseases in China and the United States with a market capitalization of around 1.51 billion HK $.

Operations: The company's sales are mainly generated from its biotechnology segment, which focuses specifically on startups and corresponds to 54.99 million yen.

Market capitalization: HK $ 1.51b

Brii Biosciences with a market capitalization of $ 1.51 billion has currently been biased and unprecedented, but has made progress by reducing losses in the past five years. The company benefits from strong short -term wealth coverage over the liabilities and a money road of more than three years. The latest developments include a license agreement with Joincare Pharmaceutical for Brii-693, which may generate future milestone payments and license fees. Despite an inexperienced board, the Brii management team is experienced what can help navigate strategic partnerships such as this, in which BRII-693 strengthens its financial position in the biotech sector.

Simply Wall ST Financial Health Rating: ★★★★★ ☆

Overview: Cortina Holdings Limited is an investment wood company that is involved in the sales and retail of timepieces and accessories in Singapore, Malaysia, Thailand, Indonesia, Hong Kong, Taiwan and internationally with a market capitalization of 581.18 million SGD.

Operations: The company's turnover mainly comes from its retail segment, which is 809.40 million SGD, followed by the wholesale segment, which contributes 115.04 million SGD.

Market capitalization: SGD581.18m

Cortina Holdings with a market capitalization of 581.18 million SGD shows solid financial health, since the short -term assets cover both short and long -term liabilities. Although it does not exceed the special sales industry in recent profit growth, it keeps a high quality result and a low price-performance ratio of 9.1x compared to the SG market average. The company has increased its debt ratio over five years, but remains well covered by the operation of cash flow and interest payments. The latest announcements include a stable net profit growth to 63.6 million SGD and proposed dividends of a total of 16 cents per share for the financial year that ended on March 31, 2025.

This article by Simply Wall Street is a general nature. We offer comments based on historical data and analyst forecasts that only use an impartial methodology, and our articles are not intended as financial advice. It is not a recommendation to buy or sell shares, and does not take into account your goals or your financial situation. We would like to use a long -term focused analysis by basic data. Note that our analysis may not take into account the latest record -sensitive announcements or qualitative material. Simply Wall Street has no position in the stocks mentioned.

In this article, Sehk discussed: 1121 Sehk: 2137 and SGX: C41.

This article was originally published by Simply Wall St.

Have feedback on this article? Worried about the content? Make sure you contact us. Alternatively, send an email to Redaktionsteam@simplywallst.com